AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide in Nigeria
16 products registered with NAFDAC — 16 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Odizat HCT 10/160/12.5 mg Tablets_ Tablet | A4-101743 | Bezik Pharma Limited | active | 25 Nov 2030 |
| Odizat HCT 10/160/25 mg Tablets_ Tablet | A4-101744 | Bezik Pharma Limited | active | 25 Nov 2030 |
| Avsar Plus 160/10/25 mg Tablet Tablet | A4-101595 | Fensyl MHP Consulting Limited | active | 28 Oct 2030 |
| Avsar Plus 320/10/25 mg_ Tablet | A4-101485 | Fensyl MHP Consulting Limited | active | 26 Aug 2030 |
| Avsar Plus 160/10/12.5 mg Tablet_ Tablet | A4-101487 | Fensyl MHP Consulting Limited | active | 26 Aug 2030 |
| Avsar Plus 160/5/25 mg Tablet_ Tablet | A4-101486 | Fensyl MHP Consulting Limited | active | 26 Aug 2030 |
| Trivalam H Tablet Tablet | A4-100774 | Expharlab Limited | active | 26 Mar 2029 |
| Amlodipine 5 mg, Valsartan 160 mg, Hydrochlorothiazide 12.5 mg Tablet | A4-100740 | Embassy Pharmaceutical and Chemicals Limited | active | 27 Feb 2029 |
| Amlodipine 5 mg, Valsartan 160 mg, Hydrochlorothiazide 25 mg Tablet (active ingredient spelling) Tablet | A4-100739 | Embassy Pharmaceutical and Chemicals Limited | active | 27 Feb 2029 |
| Amlodipine 10 mg, Valsartan 160 mg, Hydrochlorothiazide 25 mg** Tablet | A4-100703 | Embassy Pharmaceutical and Chemicals Limited | active | 30 Jan 2029 |
| Amlodipine 10 mg, Valsartan 160 mg, Hydrochlorothiazide 12.5 mg** Tablet | A4-100702 | Embassy Pharmaceutical and Chemicals Limited | active | 30 Jan 2029 |
| Exforge HCT 10/160/25 mg** Tablet | A4-5826 | Novartis Nigeria Limited | active | 20 Dec 2028 |
| Exforge HCT 10 mg/320 mg/25 mg Tablet** (duplicate) Tablet | B4-1427 | Novartis Nigeria Limited | active | 20 Dec 2025 |
| Exforge HCT 5 mg/160 mg/25 mg Tablet** Tablet | A4-5824 | Novartis Nigeria Limited | active | 9 Nov 2025 |
| Exforge HCT 5 mg/160 mg/12.5 mg Tablet** Tablet | A4-5827 | Novartis Nigeria Limited | active | 9 Nov 2025 |
| Exforge HCT 10 mg/160 mg/12.5 mg Tablets** (duplicate) Tablet | A4-5825 | Novartis Nigeria Limited | active | 9 Nov 2025 |
Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide — NAFDAC Registration Details
NAFDAC (Nigeria) has 16 registered products containing Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide, of which 16 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.